Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients-Reference-Cited by-同舟云学术

Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients

Published:2021-01-01 Issue:1 Volume:26 Page:215-224
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Varghese Chris¹,Liu Valery Yizhuo²,Immanuel Tracey¹,Chien Nicole³⁴,Green Taryn¹,Chan George¹³⁴,Theakston Edward⁴,Kalev-Zylinska Maggie¹⁴^ORCID

Affiliation:

1. Blood and Cancer Biology Laboratory, Department of Molecular Medicine & Pathology, School of Medical Sciences, University of Auckland, Auckland, New Zealand

2. Department of Medicine, University of Otago, Dunedin, New Zealand

3. Department of Haematology, Auckland City Hospital, Auckland, New Zealand

4. Department of Pathology and Laboratory Medicine, LabPlus Haematology, Auckland City Hospital, Auckland, New Zealand

Funder

Leukaemia and Blood Cancer New Zealand

University of Auckland

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.1882146

Reference53 articles.

1. 15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA

2. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene

3. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

4. Mechanisms and management of coagulopathy in acute promyelocytic leukemia

5. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIR-320a/b inhibits cell viability and cell cycle progression by targeting aryl hydrocarbon receptor nuclear translocator-like in acute promyelocyte leukaemia;Polish Journal of Pathology;2022

2. Cancer care disparities among Australian and Aotearoa New Zealand Indigenous peoples;Current Opinion in Supportive & Palliative Care;2021-07-06

3. The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry;Current Oncology;2021-04-18